Keywords: ایمنی ضد تومور; 5FU; fluorouracil 5%; CMOBC; cutaneous metastases of breast cancer; MBC; metastatic breast cancer; TLR7; toll-like receptor 7; antitumor immunity; breast cancer; cryotherapy; cutaneous metastases; fluorouracil; imiquimod; in situ vaccination; skin-direct
مقالات ISI ایمنی ضد تومور (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ایمنی ضد تومور; Antitumor immunity; Autophagy; Conventional chemotherapy; ER stress; Immunogenic cell death; Immunosurveillance;
Keywords: ایمنی ضد تومور; High-intensity focused ultrasound; Breast cancer; Antigen presenting cell; Dendritic cell; Antitumor immunity; Thermal ablation;
Keywords: ایمنی ضد تومور; Metronomic chemotherapy; Angiogenesis; Antitumor immunity; Endothelial cell; Immunosuppression;
Keywords: ایمنی ضد تومور; Cancer immunoediting; Antitumor immunity; T-cell receptor zeta; Arginase 1; Inmunoedición del cáncer; Inmunidad antitumoral; T-cell receptor zeta; Arginasa 1;
Keywords: ایمنی ضد تومور; Immunotherapy; Antitumor immunity; Metastatic melanoma; Costimulatory blockade; Innate immunity; Adaptive immunity;
Keywords: ایمنی ضد تومور; Antitumor immunity; Common variable immunodeficiency; B lymphomas; Non-Hodgkin's lymphoma; Epstein-Barr virusInmunidad antitumoral; Inmunodeficiencia variable común; Linfomas B; Linfoma no Hodgkin; Virus Epstein-Barr
Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial
Keywords: ایمنی ضد تومور; Immune Response Heterogeneity; Immune Therapy; Antitumor Immunity; Pancreatic Cancer Treatment; CAR; chimeric antigen receptor; CARTmeso; mesothelin-specific CAR T cells; FDG; 18F-2-fluoro-2-deoxy-D-glucose; IL; interleukin; MAV; metabolically active volu
The anti-inflammatory NHE-06 restores antitumor immunity by targeting NF-κB/IL-6/STAT3 signaling in hepatocellular carcinoma
Keywords: ایمنی ضد تومور; NHE-06; extracts of six natural herbals; TME; tumor microenvironment; Natural herbal extract; NF-κB/IL-6/STAT3 axis; Antitumor immunity; Hepatocellular carcinoma;
Alcohol-soluble polysaccharide from Astragalus membranaceus: Preparation, characteristics and antitumor activity
Keywords: ایمنی ضد تومور; ASP; alcohol-soluble polysaccharide from Astragalus membranaceus; HPGPC; high-performance gel permeation chromatography; FTIR; Fourier transform infrared spectroscopy; IC; ion chromatography; H22; murine hepatocarcinoma cells; 5-Fu; 5-fluorouracil; NK; na
Postoperative anti-PD-1 antibody treatment to reduce recurrence in a cancer ablation surgical wound
Keywords: ایمنی ضد تومور; Head and neck cancer; Surgery; Tumor recurrence; Immune checkpoint inhibitor; Antitumor immunity;
CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation
Keywords: ایمنی ضد تومور; Antitumor immunity; Daclizumab; Regulatory T cells;
OncologyChemoimmunotherapeutic effect of combined treatment with ex vivo generated antigen-presenting immune cells and conventional antitumor agents in a mouse neuroblastoma model
Keywords: ایمنی ضد تومور; GM-CSF; granulocyte-macrophage colony stimulating factor; IL-4; interleukin-4; CpG-ODN; CpG-oligodeoxynucleotide; BMDA; bone marrow-derived adherent cells; Neuroblastoma; Anticancer agent; Antitumor immunity; Cell therapy; Chemoimmunotherapy; Immunogenic
Immunothérapie et cancer du poumon : où en sommes-nous ?
Keywords: ایمنی ضد تومور; Cancer du poumon; Immunité anticancéreuse; Anti-PD1; Anti-PD-L1; Vaccins anti-tumoraux; CTLA-4; Biomarqueurs; Lung cancer; Antitumor immunity; PD-L1 expression; PD1 inhibitors; PD-L1 inhibitors; Anti-tumor vaccines; CTLA-4; Biomarkers;
Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma
Keywords: ایمنی ضد تومور; Regulated Cell Death; Antitumor Immunity; HMGB1; ATP; AURKA; aurora kinase A; DAMPs; damage-associated molecular patterns; GSK3β; glycogen synthase kinase 3 beta; HEK293; human embryonic kidney 293; HPDE; human pancreatic duct epithelial cell; ICD; immun
Generation of cancer-specific CD8+ CD69+ cells inhibits colon cancer growth
Keywords: ایمنی ضد تومور; Colon cancer; CD8 T cell; Apoptosis; Antitumor immunity; Cancer mouse model;
Células mieloides supresoras: potencial vínculo entre la enfermedad pulmonar obstructiva crónica y el cáncer de pulmón
Keywords: ایمنی ضد تومور; Inmunoedición del cáncer; Inmunidad antitumoral; T-cell receptor zeta; Arginasa 1Cancer immunoediting; Antitumor immunity; T-cell receptor zeta; Arginase 1
Oncolytic and immunologic cancer therapy with GM-CSF-armed vaccinia virus of Tian Tan strain Guang9
Keywords: ایمنی ضد تومور; Oncolytic vaccinia virus; Tian Tan strain Guang9; GM-CSF; Cancer therapy; Antitumor immunity
Primary immunodeficiencies and B-cell lymphomas
Keywords: ایمنی ضد تومور; Antitumor immunity; Common variable immunodeficiency; B lymphomas; Non-Hodgkin's lymphoma; Epstein-Barr virus; Inmunidad antitumoral; Inmunodeficiencia variable común; Linfomas B; Linfoma no Hodgkin; Virus Epstein-Barr;
STING in tumor and host cells cooperatively work for NK cell-mediated tumor growth retardation
Keywords: ایمنی ضد تومور; STING; B16Â cell line; NK cells; Antitumor immunity; Interferon;
T cell metabolic fitness in antitumor immunity
Keywords: ایمنی ضد تومور; T cell metabolism; glycolysis; IDO; PD-1; CTLA4; tumor microenvironment; antitumor immunity; checkpoint blockade
A potential role for 6-sulfo sialyl Lewis X in metastasis of bladder urothelial carcinoma
Keywords: ایمنی ضد تومور; Bladder urothelial carcinoma; 6-Sulfo sialyl Lewis X; E-selectin; High endothelial venule; Metastasis; Antitumor immunity;
A loss of antitumor therapeutic activity of CEA DNA vaccines is associated with the lack of tumor cells' antigen presentation to Ag-specific CTLs in a colon cancer model
Keywords: ایمنی ضد تومور; CEA; carcinoembryonic antigen; CFSE; carboxyfluorescein diacetate succinimidyl ester; EP; electroporation; HPV; human papillomavirus; IM; intramuscular; IT; intratumoral; i.t; intratumorally; LDH; lactate dehydrogenase; PBS; phosphate-buffered saline; s.c
Axitinib augments antitumor activity in renal cell carcinoma via STAT3-dependent reversal of myeloid-derived suppressor cell accumulation
Keywords: ایمنی ضد تومور; Axitinib; Antitumor immunity; Myeloid-derived suppressor cells; Vascular endothelial growth factor receptor; Signal transducer and activator of transcription 3MDSC, Myeloid-derived suppressor cell; RCC, Renal cell carcinoma; VEGFR, Vascular endothelial gr
Natural CD8+25+ regulatory T cell-secreted exosomes capable of suppressing cytotoxic T lymphocyte-mediated immunity against B16 melanoma
Keywords: ایمنی ضد تومور; CD8+25+ Tr cells; Exosomes; Suppression; CTL responses; Antitumor immunity;
Tumor cell-derived exosome-targeted dendritic cells stimulate stronger CD8+ CTL responses and antitumor immunities
Keywords: ایمنی ضد تومور; Tumor cell; Exosomes; Dendritic cells; Antitumor immunity; Vaccines;
Expression of membrane anchored cytokines and B7-1 alters tumor microenvironment and induces protective antitumor immunity in a murine breast cancer model
Keywords: ایمنی ضد تومور; Breast cancer; Membrane anchored cytokines; Antitumor immunity; Tumor microenvironment;
Activated Pancreatic Stellate Cells Sequester CD8+ T Cells to Reduce Their Infiltration of the Juxtatumoral Compartment of Pancreatic Ductal Adenocarcinoma
Keywords: ایمنی ضد تومور; Antitumor Immunity; Pancreatic Cancer; Mouse Model; Immune Regulation; AC; ampullary carcinoma; aPSC; activated pancreatic stellate cell; ATRA; all-trans retinoic acid; CC; cholangiocarcinoma; MDSC; myeloid-derived suppressor cell; PBD; pancreaticobiliary
Calreticulin in the immune system: ins and outs
Keywords: ایمنی ضد تومور; calreticulin; protein folding; phagocytosis; antitumor immunity; MHC class I; tapasin
Vaccination With ENO1 DNA Prolongs Survival of Genetically Engineered Mice With Pancreatic Cancer
Keywords: ایمنی ضد تومور; Th17; IFN-γ; Antitumor Immunity; ImmunotherapyBSA, bovine serum albumin; ENO1, α-enolase; IFN, interferon; Ig, immunoglobulin; IL, interleukin; KC, KrasG12D/Cre mice; KPC, KrasG12D/Trp53R172H/Cre mice; mAb, monoclonal antibody; MDSC, myeloid-derived suppr
Autophagy: shaping the tumor microenvironment and therapeutic response
Keywords: ایمنی ضد تومور; autophagy; cancer; tumor stroma; antitumor immunity; anticancer therapy; chloroquine.
Sarcoidal reactions in regional lymph nodes of patients with early stage non-small cell lung cancer predict improved disease-free survival: a pilot case-control study
Keywords: ایمنی ضد تومور; Granuloma; Early stage; Metastasis; Recurrence; Antitumor immunity;
Reversal of papilloma growth in rabbits therapeutically vaccinated against E6 with naked DNA and/or vesicular stomatitis virus vectors
Keywords: ایمنی ضد تومور; Human papillomavirus; CRPV; E6; Vaccine; Therapeutic vaccine; Vesicular stomatitis virus vector; DNA vector; Prime-boost; Antitumor immunity; Tumor growth
Induction of protective and therapeutic antitumor immunity by a DNA vaccine with C3d as a molecular adjuvant
Keywords: ایمنی ضد تومور; Antitumor immunity; C3d; VEGFR-2;
Dendritic cells pulsed with an anti-idiotype antibody mimicking Her-2/neu induced protective antitumor immunity in two lines of Her-2/neu transgenic mice
Keywords: ایمنی ضد تومور; Breast cancer; Her-2/neu; Anti-idiotype antibody; Vaccine; Antitumor immunity; Transgenic mice
CD40 ligation converts TGF-β-secreting tolerogenic CD4â8â dendritic cells into IL-12-secreting immunogenic ones
Keywords: ایمنی ضد تومور; CD40 ligation; DC subset; Tolerogenic; Immunogenic; Antitumor immunity;
Decreased expressions of CD1d molecule on liver dendritic cells in subcutaneous tumor bearing mice
Keywords: ایمنی ضد تومور; DC; dendritic cell; APC; antigen-presenting cells; CTL; cytotoxic T lymphocytes; α-GalCer; α-galactosylceramide; MNC; mononuclear cells; TB; tumor bearing; α-Galactosylceramide; CD1d; Liver dendritic cells; Antitumor immunity;
Toll-like receptor 4-dependent pathways as sensors of endogenous “danger” signals. New evidences and potential therapeutic targets
Keywords: ایمنی ضد تومور; Receptores tipo Toll; ProteÃnas Mrp; Choque séptico; HMGB1; Inmunidad frente a tumores; Terapia anticáncer; Toll-like receptors; Mrp proteins; Septic shock; HMGB1; Antitumor immunity; Cancer therapies;
Silencing invariant chain of DCs enhances Th1 response using small interfering RNA
Keywords: ایمنی ضد تومور; Small interfering RNA; Invariant chain; Dendritic cells; Antitumor immunity;
Interferon-α and cancer: Mechanisms of action and new perspectives of clinical use
Keywords: ایمنی ضد تومور; Interferon-α; Cancer; Antitumor immunity
Neuroblastoma impairs chemokine-mediated dendritic cell migration in vitro
Keywords: ایمنی ضد تومور; Neuroblastoma; Dendritic cells; CCR7; CCL19; Antitumor immunity;
Murine neuroblastoma attenuates dendritic cell cysteine cysteine receptor 7 (CCR7) expression
Keywords: ایمنی ضد تومور; Neuroblastoma; Dendritic cells; CCR7; CCL19; Antitumor immunity;
Functional characterisation of autoantibodies from patients with pediatric opsoclonus-myoclonus-syndrome
Keywords: ایمنی ضد تومور; Paraneoplastic neurological syndrome; Antineuronal autoantibodies; Antitumor immunity; Childhood; Flow cytometry;
Neutralization of tumor necrosis factor abrogates hepatic failure induced by α-galactosylceramide without attenuating its antitumor effect in aged mice
Keywords: ایمنی ضد تومور; α-Galactosylceramide; TNF; Fas-ligand; NK1.1 Ag+ T cells; Hepatotoxicity; Antitumor immunity; NKT cells; NK1.1Ag+ T cells; α-GalCer; α-galactosylceramide; MNC; mononuclear cells; Fas-L; Fas-ligand; TNFR; TNF receptor; ALT; alanine aminotransferase; LDH